Importantly, CTC-derived DNA from two patient samples revealed tumor-specific gene mutation (CTNNB1) there were not detected in matched plasma cfDNA, suggesting that potential of fixed CTCs to provide complementary or superior genomic information than cell-free DNA alone. Here, CTNNB1 is linked to neoplasm.